272 related articles for article (PubMed ID: 31341965)
1. Canine osteosarcoma genome sequencing identifies recurrent mutations in
Gardner HL; Sivaprakasam K; Briones N; Zismann V; Perdigones N; Drenner K; Facista S; Richholt R; Liang W; Aldrich J; Trent JM; Shields PG; Robinson N; Johnson J; Lana S; Houghton P; Fenger J; Lorch G; Janeway KA; London CA; Hendricks WPD
Commun Biol; 2019; 2():266. PubMed ID: 31341965
[TBL] [Abstract][Full Text] [Related]
2.
Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
[TBL] [Abstract][Full Text] [Related]
3. The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations.
Megquier K; Turner-Maier J; Morrill K; Li X; Johnson J; Karlsson EK; London CA; Gardner HL
PLoS One; 2022; 17(9):e0274383. PubMed ID: 36099278
[TBL] [Abstract][Full Text] [Related]
4. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.
Angstadt AY; Thayanithy V; Subramanian S; Modiano JF; Breen M
Cancer Genet; 2012 Nov; 205(11):572-87. PubMed ID: 23137772
[TBL] [Abstract][Full Text] [Related]
6. Genomics and the Immune Landscape of Osteosarcoma.
Wu CC; Livingston JA
Adv Exp Med Biol; 2020; 1258():21-36. PubMed ID: 32767232
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.
Chu S; Skidmore ZL; Kunisaki J; Walker JR; Griffith M; Griffith OL; Bryan JN
PLoS One; 2021; 16(2):e0246443. PubMed ID: 33556121
[TBL] [Abstract][Full Text] [Related]
8. TP53 gene mutations in canine osteosarcoma.
Kirpensteijn J; Kik M; Teske E; Rutteman GR
Vet Surg; 2008 Jul; 37(5):454-60. PubMed ID: 18986312
[TBL] [Abstract][Full Text] [Related]
9. Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma.
Das S; Idate R; Regan DP; Fowles JS; Lana SE; Thamm DH; Gustafson DL; Duval DL
Commun Biol; 2021 Oct; 4(1):1178. PubMed ID: 34635775
[TBL] [Abstract][Full Text] [Related]
10. miR-1 and miR-133b expression in canine osteosarcoma.
Leonardo L; Laura P; Serena BM
Res Vet Sci; 2018 Apr; 117():133-137. PubMed ID: 29272721
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors.
Levine RA; Forest T; Smith C
Vet Pathol; 2002 May; 39(3):372-8. PubMed ID: 12014501
[TBL] [Abstract][Full Text] [Related]
12. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
13. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
14. A single-cell RNA sequencing atlas of circulating leukocytes from healthy and osteosarcoma affected dogs.
Ammons DT; Harris RA; Hopkins LS; Kurihara J; Weishaar K; Dow S
Front Immunol; 2023; 14():1162700. PubMed ID: 37275879
[TBL] [Abstract][Full Text] [Related]
15. Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases.
Wang D; Niu X; Wang Z; Song CL; Huang Z; Chen KN; Duan J; Bai H; Xu J; Zhao J; Wang Y; Zhuo M; Xie XS; Kang X; Tian Y; Cai L; Han JF; An T; Sun Y; Gao S; Zhao J; Ying J; Wang L; He J; Wang J
Cancer Res; 2019 Jan; 79(1):7-20. PubMed ID: 30389703
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans.
Mannheimer JD; Tawa G; Gerhold D; Braisted J; Sayers CM; McEachron TA; Meltzer P; Mazcko C; Beck JA; LeBlanc AK
Commun Biol; 2023 Aug; 6(1):856. PubMed ID: 37591946
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive biomarkers of canine osteosarcoma.
Selvarajah GT; Kirpensteijn J
Vet J; 2010 Jul; 185(1):28-35. PubMed ID: 20493743
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant 1 copper chaperone gene expression and copper levels in dog osteosarcoma patients.
Rivera PL; Li WT; Bhogal S; Mandell JB; Belayneh R; Hankins ML; Payne JT; Watters RJ; Weiss KR
Vet Comp Oncol; 2023 Sep; 21(3):559-564. PubMed ID: 37148200
[TBL] [Abstract][Full Text] [Related]
19. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
20. Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.
Becerra MF; Reznik E; Redzematovic A; Tennenbaum DM; Kashan M; Ghanaat M; Casuscelli J; Manley B; Jonsson P; DiNatale RG; Blum KA; Durack JC; Solomon SB; Arcila ME; Bourque C; Socci N; Carlo MI; Lee CH; Voss MH; Feldman DR; Motzer RJ; Coleman JA; Russo P; Cheng EH; Hakimi AA; Hsieh JJ
Eur Urol Focus; 2018 Dec; 4(6):986-994. PubMed ID: 29066084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]